Corporate Profile

Quince Therapeutics is a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics that transform the lives of patients suffering from debilitating and rare diseases. The company is actively seeking compelling clinical-stage assets available for in-licensing and acquisition to expand its development pipeline.

Recent Events

More events are coming soon.

Investor Relations

News Releases

30 Jan '23
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jan. 30, 2023-- Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics that transform patients’ lives, today provided an update on the company’s development

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Featured Reports

More information is coming soon.